Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
CA 2391380 A1 · Owner: Andrew, David P. · Inventors: Rastelli, Luca; Lewin, David; Pennica, Diane
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides novel polypeptides termed FCTRX polypeptides, as well as polynucleotides encoding FCTRX polypeptides and antibodies that immunospecifically bind to an FCTRX or a derivative variant, mutant, or , fragment of an FCTRX polypeptide polynucleotide or antibody. The invention additionally provides methods in which the FCTRX polypeptide polynucleotide , and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.